Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro 12.5mg is a prescription-only medicine available in the UK through a licensed prescriber following a clinical assessment — it cannot legally be sold without one. NICE's appraisal of tirzepatide (TA1026) confirmed the evidence base for this treatment, and the full clinical picture for Mounjaro makes clear why the prescribing decision requires a real clinician, not an automated checkout. If you're at 12.5mg (or expecting to reach it) you've likely already been on treatment for several months. That process matters, and so does where the pen actually comes from.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's guidance on tirzepatide (TA1026, recommendations chapter) sets a clear expectation: treatment is reviewed at each stage, and continuing at higher doses depends on a documented clinical response. The 12.5mg pen sits near the top of the licensed schedule (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg) and reaching it typically means you've been titrating for at least five months. A prescriber reviewing your case at this point isn't a formality; they're confirming that progress is appropriate, that side effects are manageable, and that the next pen is the right call for you specifically. Any route that skips that check isn't offering you Mounjaro at 12.5mg. It's offering you something in a box.
The MHRA's public guidance on GLP-1 medicines makes the stakes plain: counterfeit weight-loss pens have been seized in large quantities across the UK, including the first illicit manufacturing site producing fake tirzepatide pens, raided in 2025. Some counterfeits have contained insulin. The MHRA's Yellow Card scheme exists partly so that people who encounter suspect products can report them — worth bookmarking.
In the UK, Mounjaro is a Prescription-Only Medicine under the Human Medicines Regulations 2012. That means a qualified prescriber must assess your suitability before any supply. For 12.5mg specifically (where you're stepping up from 10mg) that assessment should include a review of your current dose response, any side effects you've experienced, and confirmation of your weight and health status.
Through a regulated online pharmacy, the process looks like this: you complete a clinical consultation, a GPhC-registered prescriber reviews it personally, ID and current weight are verified (nume uses live video weight verification), and if the clinical picture supports it, treatment is approved and dispatched. If you're transferring from another provider or requesting a dose increase, evidence of your current treatment is required, that's not bureaucracy, it's the clinical standard. You can check whether any online pharmacy is properly registered using the GPhC pharmacy register. It takes about thirty seconds and it's the single most useful thing you can do before handing over a prescription to anyone online.
For those considering the NHS route, NHS waiting lists for tirzepatide remain long in many areas, and eligibility criteria are strict and phased. Private treatment through a regulated pharmacy is the alternative for people who meet the clinical criteria but don't want to wait.
The licensed eligibility for Mounjaro covers adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present) such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. But eligibility for the medicine in principle is different from eligibility for 12.5mg in particular.
Reaching 12.5mg is a titration decision. The starting dose of 2.5mg exists to let your system adjust, nausea and GI effects are most common early on, and the gradual increase is designed to reduce them. By the time a patient is being considered for 12.5mg, a prescriber should have evidence of how earlier doses were tolerated. If you've been on treatment with a different provider and want to step up to 12.5mg, our prescribers will ask to see that history. That's standard, and it's protective. People who are pregnant, breastfeeding, trying to conceive, or under 18 are not suitable for this treatment; those exclusions apply at every dose.
If you'd like to explore where you are on the eligibility picture more broadly, our weight-loss treatment overview lays out the options available through nume in plain terms.
Here's what happens when you start a consultation for Mounjaro 12.5mg through nume. You fill in a clinical questionnaire, medical history, current medications, weight, relevant conditions. A GPhC-registered Independent Prescriber reads it the same day. Not a triage algorithm; a clinician. If you're a transfer patient or requesting a dose increase, you'll be asked for evidence of your current treatment before 12.5mg is approved.
Once approved, orders submitted before 12pm on a working day are dispatched the same day from our pharmacy. DPD delivers the next working day, tracked, in unmarked packaging. There's no subscription attached to this. Every repeat order goes through the same clinical review, your prescriber sees your case afresh each time, which is how a service built around clinical oversight should work.
Our clinical team reviews every case personally. If you have questions before starting, our FAQs cover the most common ones, or you can reach us directly through the contact page. For current stock information at this dose, check availability here.
Ready to proceed? If you're at the 7.5mg stage and wondering what comes next, you can buy 7.5mg Mounjaro through our prescribing service, with the same clinical review that applies at every dose. Patients moving up the titration schedule can also buy 12.5mg Mounjaro once a prescriber has confirmed the step-up is clinically appropriate, and if you're looking to get started at that level today, our consultation page lets you buy Mounjaro 12.5mg online with same-day prescriber review. Speak to our prescribers, the consultation is free, and the clinical review happens the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.